MALAT1 and hematologic disorder: The upregulation of MALAT1 has been observed in many solid tumors and hematological malignancies, and high expression was found to be associated with the progression of disease, chemotherapy resistance, metastatic potential, and reduced patients’ survival, implying its pro-oncogenic role [3,26,27,28,29].